Immune-related adverse events after immune checkpoint blockade-based therapy are associated with improved survival in advanced sarcoma

ABSTRACT: Immune-related adverse events after immune checkpoint blockade-based therapy are associated with improved survival in advanced sarcoma

PROVIDER: PRJNA962617 | ENA |

REPOSITORIES: ENA